PATENT CLAIM ANALYSIS

Application Number: 16110621
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["514", "001000"]

Abstract:
Provided are immediate or prolonged administration of certain salts of K ATP  channel openers such as diazoxide to a subject to achieve novel pharmacodynamic, pharmacokinetic, therapeutic, physiological, metabolic and compositional outcomes in the treatment of diseases or conditions involving K ATP  channels. Also provided are pharmaceutical formulations, methods of administration and dosing of the salts that achieve these outcomes and reduce the incidence of adverse effects in treated individuals. Further provided are method of co-administering the salts with other drugs to treat diseases of humans and animals.

Claim (Index 137):
The method of  claim 130  wherein between 300 and 500 mg of the polymorph B of diazoxide choline is administered per dose.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 96.0
- Lexical Diversity: 1.55738
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15195826', '14466852', '12391990', '13846542', '14940018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.826281729303734
- 35 USC 102 Novelty (BERT): 0.6190173875135883
- Combined Prediction Score: 0.8055552951247195
- Mean Citation Score: 534.5320320000002
- Max Citation Score: 631.9695
- Similarity Product: 476.29960278725633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test